I agree that this site is using cookies. You can find further informations here.
X
Rawstron, A.C.
158  results:
Search for persons X
?
1

Impact of minimal residual disease (MRD) in salvage autolog..:

de Tute, Ruth M. ; Cook, Gordon ; Cairns, David A....
Bone Marrow Transplantation.  59 (2024)  3 - p. 431-434 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Impact of minimal residual disease (MRD) in salvage autolog..:

de Tute, R.M ; Cook, G ; Cairns, D.A...
https://eprints.whiterose.ac.uk/207476/10/Myeloma%20X%20MRD_BMTletter%20FINAL%20copy%20%281%29.pdf.  , 2024
Link: https://eprints.whiteros..
 
?
3

Correction: "The 5th edition of The World Health Organizati..:

Alaggio, R ; Amador, C ; Anagnostopoulos, I...
https://eprints.whiterose.ac.uk/208592/1/s41375-023-01962-5.pdf.  , 2023
Link: https://eprints.whiteros..
 
?
4

The 5th edition of the world health organization classifica..:

Alaggio, Rito ; Amador, Catalina ; Anagnostopoulos, Ioannis...
http://dx.doi.org/10.18725/OPARU-47447.  , 2023
Link: https://doi.org/10.18725..
 
?
5

Correction: "The 5th edition of The World Health Organizati..:

Alaggio, Rita ; Amador, Catalina ; Anagnostopoulos, Ioannis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457187/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Ibrutinib and rituximab versus fludarabine, cyclophosphamid..:

Hillmen, P ; Pitchford, A ; Bloor, A...
https://eprints.whiterose.ac.uk/201645/1/Ibrutinib%20and%20rituximab%20versus%20fludarabine,.pdf.  , 2023
Link: https://eprints.whiteros..
 
?
7

Correction. "The 5th edition of The World Health Organizati..:

Alaggio, Rita ; Amador, Catalina ; Anagnostopoulos, Ioannis...
info:eu-repo/semantics/altIdentifier/pmid/37468552.  , 2023
Link: https://hdl.handle.net/1..
 
?
8

A Personalized Rituximab Retreatment Approach Based on Clin..:

Arnold, Jack ; Vital, Edward M. ; Dass, Shouvik...
Frontiers in Immunology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
9

S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS ..:

Hillmen, P. ; Pitchford, A. ; Bloor, A....
HemaSphere.  6 (2022)  - p. 46-47 , 2022
Link: https://doi.org/10.1097/..
 
?
10

Predicting Sustained Clinical Response to Rituximab in Mode..:

Pepple, Sophanit ; Arnold, Jack ; Vital, Edward M....
ACR Open Rheumatology.  4 (2022)  8 - p. 689-699 , 2022
Link: https://doi.org/10.1002/..
 
?
11

Comprehensive genetic and functional analyses of Fc gamma r..:

Robinson, James I. ; Md Yusof, Md Yuzaiful ; Davies, Vinny...
eBioMedicine.  86 (2022)  - p. 104343 , 2022
Link: https://doi.org/10.1016/..
 
?
12

P245 Identifying predictors of short-term response to ritux..:

Pepple, Sophanit ; Arnold, Jack ; Vital, Edward M...
Rheumatology.  61 (2022)  Supplement_1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
13

OA13 Comprehensive genetic and functional analyses of Fc ga..:

Yusof, Md Yuzaiful Md ; Robinson, James I ; Davies, Vinny...
Rheumatology.  61 (2022)  Supplement_1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
14

DataSheet_1_A Personalized Rituximab Retreatment Approach B..:

Jack Arnold (748154) ; Edward M. Vital (9031103) ; Shouvik Dass (11935241)...
https://figshare.com/articles/dataset/DataSheet_1_A_Personalized_Rituximab_Retreatment_Approach_Based_on_Clinical_and_B-Cell_Biomarkers_in_ANCA-Associated_Vasculitis_docx/18228407.  , 2022
Link: https://doi.org/10.3389/..
 
?
15

A Personalized Rituximab Retreatment Approach Based on Clin..:

Arnold, Jack ; Vital, Edward M ; Dass, Shouvik...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789753/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15